CARBIDOPA\ENTACAPONE\LEVODOPA: 2,367 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
2,367
Total FAERS Reports
298 (12.6%)
Deaths Reported
904
Hospitalizations
2,367
As Primary/Secondary Suspect
109
Life-Threatening
73
Disabilities
First Report: 1999 · Latest Report: 20250903
What Are the Most Common CARBIDOPA\ENTACAPONE\LEVODOPA Side Effects?
#1 Most Reported
Parkinson's disease
361 reports (15.3%)
#2 Most Reported
Fall
217 reports (9.2%)
#3 Most Reported
Hallucination
172 reports (7.3%)
All CARBIDOPA\ENTACAPONE\LEVODOPA Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Parkinson's disease | 361 | 15.3% | 34 | 79 |
| Fall | 217 | 9.2% | 10 | 109 |
| Hallucination | 172 | 7.3% | 12 | 86 |
| Dyskinesia | 168 | 7.1% | 4 | 75 |
| Dysphagia | 165 | 7.0% | 12 | 69 |
| Wrong technique in product usage process | 163 | 6.9% | 6 | 56 |
| Tremor | 145 | 6.1% | 10 | 54 |
| Gait disturbance | 142 | 6.0% | 6 | 58 |
| Confusional state | 137 | 5.8% | 4 | 82 |
| Death | 136 | 5.8% | 136 | 11 |
| Drug ineffective | 110 | 4.7% | 5 | 21 |
| Malaise | 106 | 4.5% | 6 | 37 |
| Weight decreased | 87 | 3.7% | 11 | 45 |
| Asthenia | 84 | 3.6% | 3 | 38 |
| Depression | 74 | 3.1% | 10 | 33 |
| Nausea | 74 | 3.1% | 23 | 39 |
| Somnolence | 74 | 3.1% | 9 | 23 |
| Fatigue | 73 | 3.1% | 8 | 15 |
| Feeling abnormal | 73 | 3.1% | 2 | 17 |
| Anxiety | 70 | 3.0% | 7 | 32 |
Who Reports CARBIDOPA\ENTACAPONE\LEVODOPA Side Effects? Age & Gender Data
Gender: 49.4% female, 50.6% male. Average age: 71.4 years. Most reports from: JP. View detailed demographics →
Is CARBIDOPA\ENTACAPONE\LEVODOPA Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2001 | 7 | 5 | 7 |
| 2003 | 2 | 2 | 2 |
| 2004 | 4 | 0 | 4 |
| 2005 | 3 | 0 | 2 |
| 2007 | 9 | 2 | 2 |
| 2008 | 7 | 0 | 2 |
| 2009 | 36 | 27 | 25 |
| 2010 | 9 | 3 | 3 |
| 2011 | 16 | 3 | 11 |
| 2012 | 28 | 5 | 4 |
| 2013 | 25 | 4 | 6 |
| 2014 | 115 | 27 | 56 |
| 2015 | 157 | 10 | 67 |
| 2016 | 167 | 34 | 92 |
| 2017 | 147 | 17 | 76 |
| 2018 | 91 | 9 | 47 |
| 2019 | 78 | 9 | 36 |
| 2020 | 58 | 5 | 21 |
| 2021 | 50 | 11 | 16 |
| 2022 | 42 | 3 | 28 |
| 2023 | 31 | 1 | 19 |
| 2024 | 28 | 3 | 20 |
| 2025 | 13 | 2 | 7 |
What Is CARBIDOPA\ENTACAPONE\LEVODOPA Used For?
| Indication | Reports |
|---|---|
| Parkinson's disease | 1,499 |
| Product used for unknown indication | 509 |
| Parkinsonism | 66 |
| On and off phenomenon | 17 |
| Extrapyramidal disorder | 7 |
| Progressive supranuclear palsy | 7 |
| Dementia alzheimer's type | 6 |
| Dementia | 5 |
| Movement disorder | 5 |
| Multiple system atrophy | 5 |
CARBIDOPA\ENTACAPONE\LEVODOPA vs Alternatives: Which Is Safer?
CARBIDOPA\ENTACAPONE\LEVODOPA vs CARBIDOPA\LEVODOPA
CARBIDOPA\ENTACAPONE\LEVODOPA vs CARBIMAZOLE
CARBIDOPA\ENTACAPONE\LEVODOPA vs CARBOCYSTEINE
CARBIDOPA\ENTACAPONE\LEVODOPA vs CARBOMER
CARBIDOPA\ENTACAPONE\LEVODOPA vs CARBON DIOXIDE
CARBIDOPA\ENTACAPONE\LEVODOPA vs CARBON MONOXIDE
CARBIDOPA\ENTACAPONE\LEVODOPA vs CARBOPLATIN
CARBIDOPA\ENTACAPONE\LEVODOPA vs CARBOPROST TROMETHAMINE
CARBIDOPA\ENTACAPONE\LEVODOPA vs CARBOXYMETHYLCELLULOSE
CARBIDOPA\ENTACAPONE\LEVODOPA vs CARBOXYMETHYLCELLULOSE\GLYCERIN
Official FDA Label for CARBIDOPA\ENTACAPONE\LEVODOPA
Official prescribing information from the FDA-approved drug label.